Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Locations sections were updated to include Massachusetts and Region Sjælland. The headings 'Massachusetts Locations' and 'Region Sjælland Locations' were removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-24T14:59:12.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Minor wording updates in the Publications section (describing PubMed auto-fill) and a revision tag change from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:44:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A government funding notice banner was removed from the page. The study details, status, and eligibility criteria remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:27:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page. The content remains focused on the AVANOVA study details (NCT02354131), including design, eligibility, and locations.
    Difference
    0.3%
    Check dated 2025-11-03T21:30:29.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    3%
    Check dated 2025-10-06T07:53:37.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    - Added a new version tag (v3.1.0). - Removed a specific resource (Ovarian cancer) and an older revision (v3.0.2).
    Difference
    0.4%
    Check dated 2025-09-29T04:24:51.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.